FHIR Clinical Guidelines (v1.0.0) (STU1)

Clinical Practice Guidelines, published by Clinical Decision Support WG. This is not an authorized publication; it is the continuous build for version 1.0.0). This version is based on the current content of https://github.com/HL7/cqf-recommendations/ and changes regularly. See the Directory of published versions

PlanDefinition-chf-lasix

Formats: XML, JSON, Turtle

Generated Narrative

Resource "chf-lasix"

Profile: CPGRecommendationDefinition

knowledgeCapability: shareable

knowledgeCapability: computable

knowledgeCapability: publishable

knowledgeRepresentationLevel: structured

partOf: CHF Hypervolemia

enabled: true

url: http://hl7.org/fhir/uv/cpg/PlanDefinition/chf-lasix

version: 1.0.0

name: CHFLASIX

title: CHF LASIX

type: ECA Rule (PlanDefinitionType#eca-rule)

status: draft

experimental: true

date: 2022-02-02T20:41:50Z

publisher: HL7 International - Clinical Decision Support WG

description: Administer LASIX IV, transition to PO as appropriate

jurisdiction: World (m49.htm#001)

Goals

-DescriptionStart
*Transition to LASIX PO ()Admission to hospital (SNOMED CT#32485007)

action

title: LASIX IV

description: Administer LASIX IV

code: Dispense Medications (CPG Common Process#dispense-medications)

condition

kind: stop

definition: http://hl7.org/fhir/uv/cpg/ActivityDefinition/chf-lasix-iv

action

title: LASIX PO

description: Administer LASIX PO

code: Dispense Medications (CPG Common Process#dispense-medications)

condition

kind: start

definition: http://hl7.org/fhir/uv/cpg/ActivityDefinition/chf-lasix-po